Casdin Capital is a New York-based venture capital firm investing in life sciences, healthcare, biotechnology, synthetic biology and technology companies. Its research-driven strategy centers on molecular information, precision medicine and information platforms, and it has acted as a lead investor in life sciences companies. The firm invests in the United States and is relevant for founders in biotech, HealthTech, pharmaceuticals, synthetic biology, data and analytics companies seeking venture or later-stage VC capital.